跳到主要內容
:::

謝承恩 醫師

頭頸癌/鼻咽癌、肝膽胰及大腸直腸癌等、質子放射治療、影像導航強度調控放射治療、立體定位放射線手術、腫瘤生物學及免疫學

教職 : 助理教授

醫師網路掛號

※直接點選進入醫師網路掛號畫面※

語言

  • 國語,英語,閩南語

現職

  • 林口長庚 放射腫瘤科 主治醫師

學歷

  • 美國德州大學安德森癌症中心博士 腫瘤生物學及免疫學雙主修
  • 長庚大學醫學系畢業

經歷

  • 2021~ 林口長庚放射腫瘤科助理教授級主治醫師
  • 2018~2022美國德州大學安德森癌症中心 博士學位進修
  • 2017~2018 美國德州大學安德森癌症中心 醫師研究員
  • 2017~2021 林口長庚放射腫瘤科講師級主治醫師
  • 2015~2017 林口長庚放射腫瘤科一般級主治醫師
  • 2011~2015 林口長庚放射腫瘤科住院醫師
  • 2010~2011 臺北市立聯合醫院仁愛院區內科住院醫師

學會與認證

  • American Society for Radiotherapy and Oncology (ASTRO)
  • Society for Immunotherapy of Cancer (SITC)
  • European Society for Radiotherapy and Oncology (ESTRO)
  • 台灣放射腫瘤學會

論文及期刊發表

  • ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
  • Technological Advances in Radiotherapy.
  • Pretreatment primary tumor and nodal SUVmax values on 18F-FDG PET/CT images predict prognosis in patients with salivary gland carcinoma.
  • Pretreatment primary tumor SUVmax on 18F-FDG PET/CT images predicts outcomes in patients with salivary gland carcinoma treated with definitive intensity-modulated radiation therapy.
  • Predictors of radiation-induced liver disease in eastern and western patients with hepatocellular carcinoma undergoing proton beam therapy.
  • Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.
  • Prognostic value of tumor heterogeneity and SUVmax of pretreatment 18F-FDG PET/CT for salivary gland carcinoma with high-risk histology.
  • Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience.
  • High metastatic node number, not extranodal extension as a node-related prognosticator in pathologically node-positive salivary gland carcinomas.
長庚醫院智能服務 有任何問題隨時找我!